Restasis (Cyclosporine ophthalmic emulsion, 0.05%) Allergan

News
Article

New formulation: Drug increases tear production in patients with chronic dry eye due to ocular inflammation

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Survey: Part B Price Negotiation Could have Significant Impact on Providers

Survey: Part B Price Negotiation Could have Significant Impact on Providers

Denise Myshko
September 16th 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
September 16th 2025
Podcast

Listen

asian child getting eyes checked | ©Tan Kian Khan

In the Eye of the Beholder: Mixed Results From Study of the Risks of Atropine Drops for Myopia in Children

Peter Wehrwein, Managing Editor
September 16th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
September 16th 2025
Podcast

Listen

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

Denise Myshko
September 16th 2025
Article

Read More

Nomad_Soul-stock@adobe.com

Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s

Denise Myshko
September 16th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.